Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Rinvoq Approved For Crohn’s Disease In Pivotal Year For AbbVie’s Immunology Business
7th US Indication For The JAK Inhibitor, 2nd In IBD
May 19 2023
•
By
Mandy Jackson
Rinvoq is now approved in the US for two inflammatory bowel disease indications • Source: Shutterstock
More from New Products
More from Scrip